newsfilter
← Latest News
GlobeNewswire·

Homology Medicines Appoints Albert Seymour, Ph.D., Chief Executive Officer

Arthur Tzianabos, Ph.D., Named Chairperson of the Board of Directors BEDFORD, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (NASDAQ:FIXX), a genetic medicines company, announced today the promotion of Albert Seymour, Ph.D., to